DK1711834T3 - Fremgangsmåde til screening af glycoform-specifikke antistoffer - Google Patents

Fremgangsmåde til screening af glycoform-specifikke antistoffer

Info

Publication number
DK1711834T3
DK1711834T3 DK05701355.9T DK05701355T DK1711834T3 DK 1711834 T3 DK1711834 T3 DK 1711834T3 DK 05701355 T DK05701355 T DK 05701355T DK 1711834 T3 DK1711834 T3 DK 1711834T3
Authority
DK
Denmark
Prior art keywords
glycoform
glycoprotein
state
determined
screening
Prior art date
Application number
DK05701355.9T
Other languages
English (en)
Inventor
Catherine Ronin
Sandrine Donadio
Original Assignee
Centre Nat Rech Scient
Univ Provence Aix Marseille 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Provence Aix Marseille 1 filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK1711834T3 publication Critical patent/DK1711834T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05701355.9T 2004-02-04 2005-02-04 Fremgangsmåde til screening af glycoform-specifikke antistoffer DK1711834T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290290 2004-02-04
PCT/EP2005/001160 WO2005076013A2 (en) 2004-02-04 2005-02-04 Process for screening glycoform-specific antibodies

Publications (1)

Publication Number Publication Date
DK1711834T3 true DK1711834T3 (da) 2010-11-29

Family

ID=34833783

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05701355.9T DK1711834T3 (da) 2004-02-04 2005-02-04 Fremgangsmåde til screening af glycoform-specifikke antistoffer

Country Status (8)

Country Link
US (1) US8431355B2 (da)
EP (1) EP1711834B1 (da)
AT (1) ATE476666T1 (da)
CA (1) CA2554968C (da)
DE (1) DE602005022675D1 (da)
DK (1) DK1711834T3 (da)
ES (1) ES2350298T3 (da)
WO (1) WO2005076013A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075906A2 (en) * 2005-12-23 2007-07-05 Kelly James D Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
US20070218503A1 (en) 2006-02-13 2007-09-20 Mitra Robi D Methods of polypeptide identification, and compositions therefor
US7879799B2 (en) 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JP6087338B2 (ja) 2011-03-31 2017-03-01 フェリング ベスローテン フェンノートシャップ 医薬製剤
EP2900264A4 (en) * 2012-09-26 2016-05-25 Momenta Pharmaceuticals Inc GLYKOPROTEINZUBEREITUNGEN
WO2014191240A1 (en) * 2013-05-29 2014-12-04 F. Hoffmann-La Roche Ag Quantitative control of sialylation
WO2015001033A1 (en) * 2013-07-05 2015-01-08 F. Hoffmann-La Roche Ag Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants
EP2824176A1 (en) * 2013-07-11 2015-01-14 Siamed'xpress Methods for producing sialylated therapeutic proteins
EP3037527A1 (en) * 2014-12-22 2016-06-29 F. Hoffmann-La Roche AG Sialyltransferase without CMP-dependent sialidase activity
JP2018500934A (ja) 2014-12-22 2018-01-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｃｍｐ依存性シアリダーゼ活性
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976876A (en) * 1995-12-11 1999-11-02 The Trustees Of Columbia University In The City Of New York Antibodies specific for hLH β core fragment
WO1999039202A1 (en) * 1998-02-03 1999-08-05 The Trustees Of Columbia University In The City Of New York DETERMINATION OF THE AMOUNT OF hLHβ CORE FRAGMENT IN A SAMPLE FROM A SUBJECT AND USES THEREOF
US6528269B1 (en) * 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
EP1143250A3 (en) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Test methods and devices for analyte isoforms

Also Published As

Publication number Publication date
ES2350298T3 (es) 2011-01-20
CA2554968A1 (en) 2005-08-18
EP1711834B1 (en) 2010-08-04
US8431355B2 (en) 2013-04-30
EP1711834A2 (en) 2006-10-18
US20080199892A1 (en) 2008-08-21
WO2005076013A2 (en) 2005-08-18
WO2005076013B1 (en) 2007-03-08
DE602005022675D1 (de) 2010-09-16
ATE476666T1 (de) 2010-08-15
CA2554968C (en) 2012-03-27
WO2005076013A3 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
DK1711834T3 (da) Fremgangsmåde til screening af glycoform-specifikke antistoffer
WO2008094538A3 (en) Regulatory t cell epitopes, compositions and uses thereof
GB202101720D0 (en) Sars-cov-2 (sars2, covid-19) antibodies
WO2006071856A3 (en) Immunoglobulins comprising predominantly a man5glcnac2 glycoform
WO2008031577A8 (en) Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
NZ595464A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
NZ700473A (en) Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
NZ584838A (en) Novel antibodies which bind alpha5beta1 (fibronectin receptor) and uses thereof
EP2418224A3 (en) Reducing the risk of human and anti-human antibodies through V gene manipulation
WO2008079995A3 (en) Conjugate of natriuretic peptide and antibody constant region
NO20071419L (no) Polypeptidvarianter med endret effektorfunksjon
WO2006066568A3 (de) Monokonale agonistische anti-ctla-4 antikörper
MY159517A (en) A monoclonal antibody and a method thereof
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
WO2009040134A8 (en) Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
NZ598770A (en) Monoclonal antibodies
EP2025749A4 (en) HUMANIZED ANTI-HUMAN-EASTOPONTIN ANTIBODY
UA108346C2 (uk) Спосіб модулювання антагоністичної активності моноклонального антитіла
DE50311921D1 (de) Mikropartikel mit cd28-spezifischen monoklonalen antikoerpern
WO2009048769A3 (en) Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
WO2011138557A3 (fr) Utilisation d'anticorps anti-cd71 pour la préparation d'un médicament
WO2007049152A3 (en) Methods of producing stable b-lymphocytes
ATE446314T1 (de) Methode zur reinigung von fsh
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2008085502A3 (en) A green fluorescent protein optimized for expression with self-cleaving polypeptides